Ocular Therapeutix Inc. (OCUL) Fundamentals

Ocular Therapeutix Inc is a biotechnology company that specializes in therapies for diseases and conditions of the eye. The company uses its proprietary hydrogel platform technology to deliver therapeutic agents to the eye. Its pipeline consists of eye medication that aims to overcome the limitations of current eye-drop-based therapies for ophthalmic diseases and conditions. Ocular Therapeutix aims to offer medication to replace the existing eye-drop therapy regimen, with the aim of lasting weeks or months with a one-time product application.
SHARE INFORMATION
Market Cap$ 298,800,294
Shares Outstanding77,010,385
Float70,725,680
Percent Float91.84%
Short Interest0.00
Short Percent Float0.0%
Short Interest Ratio0.00
Short Interest Date-
Latest Fiscal Dividend Per Share$ 0.00
Latest Fiscal Revenue$ 43,521,000
Latest Fiscal EPS$ -0.95
Latest Fiscal Date2021-12-31
DIVIDENDS
Dividend (3 Years)$ 0.00
Dividend (5 Years)$ 0.00
Ex Dividend Date-
Dividend Rate$ 0.00
Dividend Yield0.0%
Payment Cash-
HOLDERS
Institutions291
Institutional Holdings Date2022-12-31
Institutional Bought Previous 3 Months2,217,761
Institutional Holdings Percent84.8%
Institutional Sold Previous 3 Months7,607,797
Insider Holdings Date2022-12-31
Insider Bought Previous 3 Months43,328
Insider Holdings Percent3.1
Insider Sold Previous 3 Months-
Insider Shares Owned2,379,050
TRADING INFO
52 Week High$ 6.53
52 Week Low$ 2.57
52 Week High Change$ -31.08
21 Day Moving Average$ 3.4914
21 Day Extended Moving Average$ 3.6233
50 Day Moving Average$ 3.1614
50 Day Extended Moving Average$ 3.4636
200 Day Moving Average$ 3.9981
200 Day Extended Moving Average$ 4.3988
10 Day Average Volume626,649
20 Day Average Volume689,360
30 Day Average Volume721,856
50 Day Average Volume626,394
Alpha0.002630
Beta1.3316
Standard Deviation0.210872
R20.115950
7 Day Price Change$ -0.22
7 Day Percent Change-5.37%
21 Day Price Change$ 0.71
21 Day Percent Change22.4%
30 Day Price Change$ 1.21
30 Day Percent Change45.32%
Month to Date Price Change$ 1.07
Month to Date Percent Change38.08%
Quarter to Date Price Change$ 1.07
Quarter to Date Percent Change38.08%
180 Day Price Change$ -0.38
180 Day Percent Change-8.92%
200 Day Price Change$ -0.61
200 Day Percent Change-13.59%
Year to Date Price Change$ 1.07
Year to Date Percent Change38.08%

Ocular Therapeutix Inc. (OCUL) Key Ratios

PROFITABILITY
EBIT Margin-105.6%
EBITDA Margin-101.2%
Pre-Tax Profit Margin-1,855.8%
Profit Margin Count-93.57%
Gross Margin90.7%
Profit Margin TOT-93.57%
INCOME STATEMENTS
Revenue$ 37,419,000
Revenue Per Share$ 0.4859
Revenue (3 Years)$ 0.00
Revenue (5 Years)$ 0.00
FINANCIAL STRENGTH
Price to Tangible Book6.50
Total Debt To Equity1.30
Int Coverage-7.70
Current Ratio5.00
Leverage Ratio2.70
Quick Ratio4.80
Long Term Debt To Capital0.56
VALUATION MEASURES
PE Ratio-3.90
Enterprise Value$ 239,858,605
Price to Sales7.9853
Price to Free Cash-6.80
PE High Last 5 Years-3.50
Price To Book6.50
Price To Cash Flow0.00
PE Low Last 5 Years-2.30
Price to Tangible Book6.50
MANAGEMENT EFFECTIVENESS
Receivables Turnover2.00
Invoice Turnover3.50
Assets Turnover0.20
Return Assets-34.60
Return on Equity-98.73
Return on Capital-41.96

Ocular Therapeutix Inc. (OCUL) Profile

PROFILE INFO
Issue TypeCS
SEC TypeEQS
AuditorPricewaterhouseCoopers LLP
CEOAntony C. Mattessich
Emplyoees228
Last AuditUQ
CIK0001393434
IndustryBiotechnology
SectorHealthcare
NAICSPharmaceutical Preparation Manufacturing(325412)
CONTACT INFO
Address24 Crosby Drive
Bedford, MA 1730
Websitehttp://www.ocutx.com
Facsimile+1 781 357-4001
Telephone+1 781 357-4000
Emaildnotman@ocutx.com


Your Recent History
NASDAQ
OCUL
Ocular The..
Register now to watch these stocks streaming on the ADVFN Monitor.

Monitor lets you view up to 110 of your favourite stocks at once and is completely free to use.

Log in to InvestorsHub
Register Now

NYSE, AMEX, and ASX quotes are delayed by at least 20 minutes.
All other quotes are delayed by at least 15 minutes unless otherwise stated.